Clinical Trial: Computer-Assisted Cancer Risk Behavior Counseling
This study is not yet open for patient recruitment.
Verified by Thomas Jefferson University May 2005
| Sponsors and Collaborators: | Thomas Jefferson University National Cancer Institute (NCI) | | Information provided by: | Thomas Jefferson University | | ClinicalTrials.gov Identifier: | NCT00242645 | |
Purpose
To test whether or not giving patients information before their doctor visits changes the care they receive and what type of information is best to give before the doctor visit.
| Condition | Intervention | Phase |
Diabetes Diabetes Mellitus Hypertension
| Behavior: Health Information Behavior: Preventive Services Behavior: Computer tailored information
| Phase I
|
MedlinePlus related topics: Diabetes; High Blood Pressure
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Further study details as provided by Thomas Jefferson University:
Primary Outcomes: To test the effect of receiving computer tailored information about
diabetes care before doctor visits and the differential effecto of varying types of information
Secondary Outcomes: Patient exit interviews after doctor visits about what happended during the visits, such as what was dicussed, what tests and consults were ordered and what medications were added or changed.
Expected Total Enrollment: 200
Study start: May 2006; Expected completion: July 2007
Last follow-up: May 2007; Data entry closure: July 2007
Patients are randomized into one of three groups. Before a single visit with
diabetes care provider, the patient is called to answer interview questions about their health, diabeticcare and behavior habits. After a patient visits with their doctor, they are called again to answer question about the visit they just had. If a patient is place into group A or B, based on their answers to the questions they are mailed a printed report before their doctor visit. The report will indicate how things are going the patient''''s diabetic care and recommended questions to ask his/her health care provided about diabetes. Group A feedback report will emphasize the risks from
diabetes and the feedback reports for Group B will emphasize things to do to protect oneself from problems from having diabetes. Participants randomized to Group C will only receive printed reports after a doctors visit. No extra visit will be scheduled with the participants doctor, no travel is required, no
blood tests are required and ther doctor will not be involved in the study unless the study participant chooses to discuss it with his/her doctor.
Eligibility
Ages Eligible for Study: 21 Years - 70 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- 18 years of age or older; has type 2 (adult-onset) diabetes; Developed diabetes after the age of 21 Has a scheduled doctor visit about diabetes in the next few months
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00242645
Christopher N. Sciamanna, MD, MPH 215-955-4376 chris.sciamanna@jefferson.edu
Nicole M. Cobb, MAOM 215-955-9995 nicole.cobb@jefferson.edu
Study chairs or principal investigators
Christopher N Sciamanna, MD, Study Chair, Thomas Jefferson Unversity
More Information
Study ID Numbers: 04F.244; 00002109
Last Updated: December 23, 2005
Record first received: October 19, 2005
ClinicalTrials.gov Identifier: NCT00242645
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2006-01-10
Source: ClinicalTrials.gov
Cache Date: January 11, 2006